Ultragenyx Pharmaceutical | RARE - 매출원가

주가
24.18
매일 변경
-0.35 -1.43%
매월
25.29%
매년
-37.97%
Q2 예상
23.58




매출원가 변화 날짜
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Insmed USD 46.16M 15.25M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Kyowa Hakko Kirin JPY 37.87B 9.67B 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Xoma 116K 112.7K 2024-06